NCT01763632

Brief Summary

Thirteen hospitals in China will participate in the study, which aims to provide data on transcutaneous bilirubin (TcB) levels for the first 168 hr after birth in term and late-preterm neonates, and develop an hour-specific TcB nomogram. The investigators hypothesize that the hour-specific TcB nomogram can predict neonatal hyperbilirubinemia in term and late-preterm Chinese infants, and plan appropriate follow-up for hyperbilirubinemia in newborns.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19,601

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Shorter than P25 for all trials

Geographic Reach
1 country

16 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 2, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 9, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

October 28, 2014

Status Verified

October 1, 2014

Enrollment Period

11 months

First QC Date

January 2, 2013

Last Update Submit

October 25, 2014

Conditions

Keywords

HyperbilirubinemiaNeonatalTranscutaneous Bilirubin

Outcome Measures

Primary Outcomes (1)

  • Change of transcutaneous bilirubin levels from baseline to each postpartum examination up to 168 hr after birth

    During the first postnatal day, transcutaneous bilirubin (TcB) measures were performed at 12-hour time intervals up to the age of 168 hr. TcB data are used to develop an hour-specific TcB nomogram.

    Every 12 hr for 168 hr.

Secondary Outcomes (1)

  • Predictive ability of an hour-specific TcB nomogram

    At the 28 days after birth

Interventions

Device: JM-103 (Minolta, Osaka, Japan, jaundice assessment) Procedure: Transcutaneous bilirubinometry (TcB)

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Term or late-preterm newborn infants from thirteen hospital in China were recruited.

You may qualify if:

  • Term or late-preterm newborn infants with GAs of ≥35 weeks and birth weights of ≥2,000 g were included.

You may not qualify if:

  • All sick newborn infants who were admitted to the intensive care unit.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

Guangdong Maternal and Children's Hospital, Guangzhou Medical College

Guangzhou, Guangdong, 510010, China

Location

Guangxi Maternal and Child Health Hospital

Liuchow, Guangxi, 530003, China

Location

Guiyang Maternal and Child Health Hospital

Guiyang, Guizhou, 550003, China

Location

The First Hospital of Harbin Medical University

Harbin, Heilongjiang, 150001, China

Location

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 410100, China

Location

Inner Mongolia Maternal and Child Health Care Hospital

Hohhot, Inner Mongolia, 010020, China

Location

Nanjing Maternity and Child Health Care Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210004, China

Location

Jinlin Provincial Maternal and Child Health Hospital

Changchun, Jilin, 130021, China

Location

Shaanxi Provincial Maternal and Child Health Hospital

Taiyuan, Shaanxi, 300013, China

Location

Shaanxi Provincial Maternal and Child Health Hospital

Xi'an, Shaanxi, 710003, China

Location

Sichuan Provincial People's Hospital

Chengdu, Sichuan, 610072, China

Location

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

Location

The First Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, 830054, China

Location

The Third Hospital of Peking University

Beijing, 100191, China

Location

Gynecology and Obstetrics Hospital, Fudan University

Shanghai, 200011, China

Location

Children's Hospital of Fudan University

Shanghai, 200032, China

Location

MeSH Terms

Conditions

Hyperbilirubinemia, NeonatalHyperbilirubinemia

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Chao Chen, PhD

    Children's Hospital of Fudan University

    STUDY DIRECTOR
  • Shuping Han, PhD

    Nanjing Maternity and Child Health Care Hospital

    STUDY DIRECTOR
  • Zhangbin Yu, PhD

    Nanjing Maternity and Child Health Care Hospital

    PRINCIPAL INVESTIGATOR
  • Chunming Jiang, PhD

    First Affiliated Hospital of Harbin Medical University

    PRINCIPAL INVESTIGATOR
  • Yan Gao, PhD

    Jinlin Provincial Maternal and Child Health Hospital

    PRINCIPAL INVESTIGATOR
  • Xiaomei Tong, PhD

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR
  • Meihua Pu, PhD

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR
  • Hongyun Wang, PhD

    Inner Mongolia Maternal and Child Health Care Hospital

    PRINCIPAL INVESTIGATOR
  • Kezhan Liu, PhD

    Shanxi Provincial Maternity and Children's Hospital

    PRINCIPAL INVESTIGATOR
  • Jin Wang, PhD

    Children's Hospital of Fudan University

    PRINCIPAL INVESTIGATOR
  • Jimei Wang, PhD

    Obstetrics & Gynecology Hospital of Fudan University

    PRINCIPAL INVESTIGATOR
  • Xiuyong Cheng, PhD

    The First Affiliated Hospital of Zhengzhou University

    PRINCIPAL INVESTIGATOR
  • Jie Yang, PhD

    Guangdong Women and Children Hospital

    PRINCIPAL INVESTIGATOR
  • Qiufen Wei, PhD

    Guangxi Maternal and Child Health Hospital

    PRINCIPAL INVESTIGATOR
  • Zhankui Li, PhD

    Shanxi Provincial Maternity and Children's Hospital

    PRINCIPAL INVESTIGATOR
  • Mingxia Li, PhD

    First Affiliated Hospital of Xinjiang Medical University

    PRINCIPAL INVESTIGATOR
  • Ling Liu, PhD

    Guiyang Maternity and Child Health Care Hospital

    PRINCIPAL INVESTIGATOR
  • Xiaofan Sun, MD

    Nanjing Maternity and Child Health Care Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 2, 2013

First Posted

January 9, 2013

Study Start

January 1, 2013

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

October 28, 2014

Record last verified: 2014-10

Locations